Dementia risk with antihypertensive use and blood pressure variability: A cohort study
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine the association between discrete antihypertensive drug classes and incident dementia controlling for blood pressure variability (BPV) in the preceding 4 years. METHODS: A total of 6,537 participants (mean age 79 years, 62% women) in a prospective population-based cohort were followed up for incident dementia. A 4-year time lag period was created to classify drug exposure and measure blood pressure. BPV (percent coefficient of variation [CV]) was regressed against 9 antihypertensive drug classes (BPVreg). Cox regression models were employed to determine hazard ratios (HRs) for incident dementia thereafter according to drug class, adjusted for mean blood pressure, covariates, and BPV or BPVreg. RESULTS: Over a median 8.4 years follow-up (interquartile range 6.7-9.0), lower dementia risk was associated with nondihydropyridine calcium channel blocker (HR 0.56; 95% confidence interval [CI] 0.31-1.00, p = 0.05) and loop diuretics (HR 0.45; 95% CI 0.22-0.93, p = 0.03) after adjusting for CV-BPV. Similar findings were obtained in analyses restricted to antihypertensive drug users for nondihydropyridine calcium channel blocker (HR 0.52; 95% CI 0.28-0.95, p = 0.03) and loop diuretics (HR 0.40; 95% CI 0.19-0.83, p = 0.01). All systolic BPV × antihypertensive drug interaction terms were not different from p < 0.05. CONCLUSIONS: Nondihydropyridine calcium channel blocker and loop diuretics were associated with a reduced dementia risk independent of CV-BPV in the preceding 4 years. Systolic BPV was not the primary mechanism through which antihypertensive drug classes lower dementia risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rothwell, P. M., Howard, S. C., Dolan, E., O'Brien, E., Dobson, J. E., Dahlöf, B., Sever, P. S., & Poulter, N. R. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60308-x · Cited by 1,784 · cited 4×
“Accumulating evidence suggests that visit-tovisit BPV is associated with adverse cardiovascular outcomes independent of mean BP.(5,6) Indeed, a parallel and emerging body of work also corroborates that BPV is associated with cognitive decline(7,8) and incident dementia risk,(9) thus broadly implicating BPV in neurolog…”
BackgroundMethodInfluentialForette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898
(2003) · Neuroepidemiology · doi:10.1159/000072920 · Cited by 672
Li, N.-C., Lee, A., Whitmer, R. A., Kivipelto, M., Lawler, E., Kazis, L. E., & Wolozin, B. (2010) · BMJ · doi:10.1136/bmj.b5465 · Cited by 486
Morris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1640 · Cited by 217 · cited 1×
“The loop diuretics were associated with lower dementia risk and earlier reports have implicated thiazide,(2) potassium-sparing,(2,35) loop,(17) and multiple diuretic classes(1,11,36) with dementia risk or cognitive function and others have reported no reduction.(12) Putative mechanisms differentiating diuretics from o…”
BackgroundDuration of antihypertensive drug use and risk of dementia: A prospective cohort study
Haag, M. D. M., Hofman, A., Koudstaal, P. J., Breteler, M. M. B., & Stricker, B. H. C. (2009) · Neurology · doi:10.1212/01.wnl.0000345062.86148.3f · Cited by 140
Calcium channel blockers and risk of AD: the Baltimore Longitudinal Study of Aging
Yasar, S., Corrada, M., Brookmeyer, R., & Kawas, C. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.03.009 · Cited by 116
Paris, D., Bachmeier, C., Patel, N., Quadros, A., Volmar, C.-H., Laporte, V., Ganey, J., Beaulieu-Abdelahad, D., Ait-Ghezala, G., Crawford, F., et al. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00180 · Cited by 114 · cited 1×
“In a recent review(30) it was questioned whether the dihydropyridines should be preferred for reducing dementia risk, citing the ability to cross the blood–brain barrier and their association with amyloid b clearance.(31) Calcium signaling is also involved in other neuronal processes including tau hyperphosphorylation…”
Background
Cited by
Ou, Y.-N., Tan, C.-C., Shen, X.-N., Xu, W., Hou, X.-H., Dong, Q., Tan, L., & Yu, J.-T. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.14993 · Cited by 402
Age of onset of hypertension and risk of dementia in the oldest‐old: The 90+ Study
Corrada, M. M., Hayden, K. M., Paganini-Hill, A., Bullain, S. S., DeMoss, J., Aguirre, C., Brookmeyer, R., & Kawas, C. H. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.007 · Cited by 176
de Heus, R. A. A., Tzourio, C., Lee, E. J. L., Opozda, M., Vincent, A. D., Anstey, K. J., Hofman, A., Kario, K., Lattanzi, S., Launer, L. J., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17797 · Cited by 138
Self-citationden Brok, M. G. H. E., van Dalen, J. W., Abdulrahman, H., Larson, E. B., van Middelaar, T., van Gool, W. A., Moll van Charante, E. P., & Richard, E. (2021) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2020.12.019 · Cited by 84
Hussain, S., Singh, A., Rahman, S. O., Habib, A., & Najmi, A. K. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.027 · Cited by 52
Metadata
- Authors
- Tully, P. J., Dartigues, J.-F., Debette, S., Helmer, C., Artero, S., & Tzourio, C.
- Venue
- Neurology
- Published
- 2016-08-09
- Volume
- 87
- Issue
- 6
- Pages
- 601-608
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2474683112
- Cited by
- 39
- References
- 8
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dementia risk with antihypertensive use and blood pressure variability: A cohort study. https://app.cochat.ai/papers/10.1212/wnl.0000000000002946
- The paper
- Tully, P. J., Dartigues, J.-F., Debette, S., Helmer, C., Artero, S., & Tzourio, C. (2016). Dementia risk with antihypertensive use and blood pressure variability: A cohort study. Neurology. https://doi.org/10.1212/wnl.0000000000002946
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.